News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current MAYND market cap is 4.39B. The company's latest EPS is AUD 0.0683 and P/E is 74.08.
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 525.21M | 456.99M | 400.78M | 400.93M | 262.48M |
| Operating Income | -337.9M | -104.12M | -230.15M | -11.86M | -233.15M |
| Net Income | -280.87M | -92.79M | -208.42M | -281.29M | 117.25M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 1.64B | 1.83B | 1.46B | 1.29B | 1.25B |
| Total Liabilities | 622.26M | 782.87M | 691.61M | 749.7M | 612.99M |
| Total Equity | 1.01B | 1.04B | 771.58M | 538.23M | 634.36M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | 106.61M | 99.78M | 58.86M | -7.21M | -42.71M |
| Investing | -91.69M | -55.87M | -49.25M | -28.53M | 473.49M |
| Financing | -15.55M | 4.52M | -40.44M | 27.6M | -431.89M |
| Market Cap | 4.39B |
| Price to Earnings Ratio | 74.08 |
| Price to Sales Ratio | 33.07 |
| Price to Cash Ratio | 93.7 |
| Price to Book Ratio | 13.68 |
| Dividend Yield | - |
| Shares Outstanding | 1.72B |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 2.61 (92.88%) |
| Company Name | Mayne Pharma Group Ltd (PK) |
| Address |
1538 main north road adelaide, south australia 5106 |
| Website | https://www.maynepharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
